down-regulated |
|
|
|
GO: 0051789 |
Response to protein stimulus |
20 |
8.08E-09 |
GO: 0006986 |
Response to unfolded protein |
15 |
1.96E-07 |
GO: 0001775 |
Cell activation |
29 |
1.80E-06 |
GO: 0046649 |
Lymphocyte activation |
23 |
3.12E-06 |
GO: 0010033 |
Response to organic substance |
51 |
6.90E-06 |
GO: 0042981 |
Regulation of apoptosis |
55 |
7.44E-06 |
GO: 0045321 |
Leukocyte activation |
25 |
7.54E-06 |
GO: 0043067 |
Regulation of programmed cell death |
55 |
9.70E-06 |
GO: 0010941 |
Regulation of cell death |
55 |
1.09E-05 |
GO: 0008284 |
Positive regulation of cell proliferation |
34 |
1.79E-05 |
KEGG: hsa04060 |
Cytokine-cytokine receptor interaction |
28 |
1.79E-05 |
KEGG: hsa04660 |
T cell receptor signaling pathway |
16 |
5.25E-05 |
KEGG: hsa04010 |
MAPK signaling pathway |
26 |
1.81E-04 |
KEGG: hsa04630 |
Jak-STAT signaling pathway |
17 |
9.75E-04 |
KEGG: hsa04062 |
Chemokine signaling pathway |
18 |
0.002763 |
KEGG: hsa04115 |
p53 signaling pathway |
9 |
0.0085092 |
KEGG: hsa05210 |
Colorectal cancer |
10 |
0.0098568 |
KEGG: hsa05220 |
Chronic myeloid leukemia |
9 |
0.0150118 |
KEGG: hsa05200 |
Pathways in cancer |
23 |
0.0252524 |
KEGG: hsa04012 |
ErbB signaling pathway |
9 |
0.0335255 |